A Quantitative Modification of VI ‐ RADS for Bladder Cancer at the Ureteral Orifice: A Reader Study on MRI With Varying Experience Levels
Journal of Magnetic Resonance Imaging · 2026
DOI: 10.1002/jmri.70401 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Magnetic Resonance Imaging, 2026. Verfasst von Erjia Guo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital, Chinese Academy of Medical S…. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Magnetic Resonance Imaging, Ureter. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: the Beijing Natural Science Foundation, the Peking Union Medical College Hospital Talent Cultivation Program (Category D), the CAMS Innovation Fund for Medical Sciences (CIFMS).
Abstract (Originalsprache)
Background
While the current Vesical Imaging Reporting and Data System (VI‐RADS) provides a valuable tool for evaluating bladder cancer, it is not tailored to the ureteral orifices and primarily relies on subjective evaluation.
Purpose
To identify significant parameters from MRI for diagnosing muscle‐invasive bladder cancer (MIBC) at the ureteral orifice, and to evaluate their incremental value to VI‐RADS for readers of varying experience. Study Type Retrospective. Population Development cohort: 81 patients with ureteral orifice bladder tumors (mean age, 68 ± 9; 60 men). External validation cohort: 34 patients (mean age, 63 ± 5; 22 men). Field Strength/Sequence 3.0 T; fast spin‐echo T2‐weighted imaging, single‐shot echo planar diffusion‐weighted imaging, 3D spoiled gradient echo T1‐weighted dynamic contrast‐enhanced imaging. Assessment Four radiologists of varying experience independently assigned VI‐RADS scores. Quantitative parameters (tumor length, tumor contact length [TCL], stalk width [SW], and K trans ) and qualitative parameters were assessed. Pathology was the reference standard. Statistical Tests Intraclass correlation coefficient, weighted κ analysis, independent samples t ‐test, Mann–Whitney U test, chi‐square test, receiver operating characteristic curve analysis, univariate and multivariate logistic regression, 1000 bootstrap resamples, DeLong's test, and McNemar's test with Bonferroni correction. Significance was defined as p < 0.05, with p < 0.008 for multiple comparisons.
Results
Multivariate analysis identified TCL (odds ratio [OR] = 1.12) and stalk width (OR = 1.74) as independent predictors. In both cohorts, the TCL + SW‐modified VI‐RADS significantly improved sensitivity over the original VI‐RADS for diagnosing MIBC at the ureteral orifice in two junior radiologists. The TCL + SW‐modified VI‐RADS did not significantly improve sensitivity compared with the TCL‐modified VI‐RADS in either cohort ( p = 0.25–0.50). Data Conclusion The integration of TCL and stalk width into the VI‐RADS improves diagnostic performance for MIBC at the ureteral orifice, particularly for less‐experienced radiologists. Nevertheless, external validation in larger, multicenter cohorts is required. Evidence Level 3. Technical Efficacy Stage 2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
- Department of Radiology, The Fourth People's Hospital of Jinan, Jinan, Shandong Province, China.
- Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
- Department of Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
- Department of Pathology, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
- Department of Radiology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
ORCID-Profile: Erjia Guo, Li Chen, Lili Xu, Hao Sun, Gumuyang Zhang
Förderung
- the Beijing Natural Science Foundation
- the Peking Union Medical College Hospital Talent Cultivation Program (Category D)
- the CAMS Innovation Fund for Medical Sciences (CIFMS)
- National High Level Hospital Clinical Research Funding
Zitieren
APA
Guo, E., Chen, L., Li, Y., Fan, P., Xie, Y., Fan, X., Ma, L., Li, X., Yang, Y., Huang, H., Xu, L., Sun, H., & Zhang, G. (2026). A Quantitative Modification of VI ‐ RADS for Bladder Cancer at the Ureteral Orifice: A Reader Study on MRI With Varying Experience Levels. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.70401
Vancouver
Guo E, Chen L, Li Y, Fan P, Xie Y, Fan X, et al. A Quantitative Modification of VI ‐ RADS for Bladder Cancer at the Ureteral Orifice: A Reader Study on MRI With Varying Experience Levels. Journal of Magnetic Resonance Imaging. 2026. doi:10.1002/jmri.70401
BibTeX
@article{Guo2026,
author = {Guo, Erjia and Chen, Li and Li, Yongliang and Fan, Peilin and Xie, Yi and Fan, Xinrong and Ma, Lin and Li, Xiaoyuan and Yang, Yushi and Huang, Houfeng and Xu, Lili and Sun, Hao and Zhang, Gumuyang},
title = {A Quantitative Modification of VI ‐ RADS for Bladder Cancer at the Ureteral Orifice: A Reader Study on MRI With Varying Experience Levels},
journal = {Journal of Magnetic Resonance Imaging},
year = {2026},
doi = {10.1002/jmri.70401}
}
EUVIMED